Long Term Follow-up for RGX-202
Long Term Follow-up for RGX-202
Enrolling by invitation · NCT06491927 · Registry updated 2026-03-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Long Term Follow-up for RGX-202 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne muscular dystrophy, Muscular Disorders, Atrophic, X-linked disease, hereditary disease, muscle tissue disorder, muscular dystrophy, musculoskeletal system disorder, nervous system disorder, neuromuscular disease | Enrolling by invitation | Not stated | 2026-03-24 | NCT06491927 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| REGENXBIO Inc. | 14 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Ann & Robert H. Lurie Children's Hospital of Chicago | Chicago | United States | 144 |
| Arkansas Children's Hospital | Little Rock | United States | 82 |
| Stanford School of Medicine /Division of Neuromuscular Medicine | Palo Alto | United States | 2 |
| The University of Texas Southwestern Medical Center | Dallas | United States | 37 |
| Virginia Commonwealth University | Richmond | United States | 156 |